Efficacy News and Research

RSS
Researchers uncover new therapeutic vulnerability in endocrine therapy-resistant breast cancers

Researchers uncover new therapeutic vulnerability in endocrine therapy-resistant breast cancers

New approach for delivering medication across the blood-brain barrier to treat brain tumors

New approach for delivering medication across the blood-brain barrier to treat brain tumors

β-cyclodextrin family found to be promising and cost-effective antiviral agents against SARS-CoV-2

β-cyclodextrin family found to be promising and cost-effective antiviral agents against SARS-CoV-2

World Antimicrobial Awareness Week: Preventing Antimicrobial Resistance Together

World Antimicrobial Awareness Week: Preventing Antimicrobial Resistance Together

The antimicrobial activity of tee tree oil nanoliposomes against Escherichia coli

The antimicrobial activity of tee tree oil nanoliposomes against Escherichia coli

Pt(IV)-conjugated drug-delivery system shows efficacy in glioblastoma therapy

Pt(IV)-conjugated drug-delivery system shows efficacy in glioblastoma therapy

Study identifies risk factors and symptom clusters associated with long-COVID

Study identifies risk factors and symptom clusters associated with long-COVID

Bispecific antibodies neutralize Sarbecoviruses with increased breadth and potency

Bispecific antibodies neutralize Sarbecoviruses with increased breadth and potency

What is the immune protection generated by SARS-CoV-2 Delta and Omicron BA.1 and BA.2 against Omicron BA.4 and BA.5?

What is the immune protection generated by SARS-CoV-2 Delta and Omicron BA.1 and BA.2 against Omicron BA.4 and BA.5?

What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?

What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?

Researchers identify a conserved site on SARS-CoV-2 spike that a broadly neutralizing macrocyclic peptide can target

Researchers identify a conserved site on SARS-CoV-2 spike that a broadly neutralizing macrocyclic peptide can target

When is it best to use dose-sparing vaccination strategies for monkeypox to protect more people?

When is it best to use dose-sparing vaccination strategies for monkeypox to protect more people?

Augmented drug preferentially eliminates cancer cells but does not harm healthy cells

Augmented drug preferentially eliminates cancer cells but does not harm healthy cells

Study finds a lower compliance rate with recently released guidelines for COVID-19 care

Study finds a lower compliance rate with recently released guidelines for COVID-19 care

SARS-CoV-2 ‘Deltacron’ variant exhibits immune-escape properties similar to Omicron BA.1

SARS-CoV-2 ‘Deltacron’ variant exhibits immune-escape properties similar to Omicron BA.1

Machine learning algorithm predicts a tumor’s response to immune checkpoint blockade

Machine learning algorithm predicts a tumor’s response to immune checkpoint blockade

COVID-19 mRNA boosters induce robust but non-durable immune response in the elderly

COVID-19 mRNA boosters induce robust but non-durable immune response in the elderly

Development of a potent, broadly protective vaccine against all SARS-CoV-2 variants

Development of a potent, broadly protective vaccine against all SARS-CoV-2 variants

Black, Hispanic MSM disproportionately affected by monkeypox

Black, Hispanic MSM disproportionately affected by monkeypox

New drug could be a game changer for cancer patients undergoing chemotherapy

New drug could be a game changer for cancer patients undergoing chemotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.